GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Marketable Securities : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is GlaxoSmithKline Pharmaceuticals Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. GlaxoSmithKline Pharmaceuticals's Marketable Securities for the quarter that ended in Dec. 2024 was ₹0 Mil.

GlaxoSmithKline Pharmaceuticals's annual Marketable Securities declined from Mar. 2022 (₹26,165 Mil) to Mar. 2023 (₹16,192 Mil) but then increased from Mar. 2023 (₹16,192 Mil) to Mar. 2024 (₹17,927 Mil).

GlaxoSmithKline Pharmaceuticals Marketable Securities Historical Data

The historical data trend for GlaxoSmithKline Pharmaceuticals's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Pharmaceuticals Marketable Securities Chart

GlaxoSmithKline Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Marketable Securities

Get a 7-Day Free Trial

9,570.15

7,577.16

26,165.40

16,191.79

17,926.52

GlaxoSmithKline Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Marketable Securities	Get a 7-Day Free Trial															-	17,926.52	-	21,411.30	-

GlaxoSmithKline Pharmaceuticals Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

GlaxoSmithKline Pharmaceuticals Marketable Securities Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pharmaceuticals's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pharmaceuticals Ltd (NSE:GLAXO) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

500660:India

Address

Dr. Annie Besant Road, GSK House, Worli, Mumbai, MH, IND, 400030

Website

https://www.gsk-india.com

GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives majority of its revenue from India.

GlaxoSmithKline Pharmaceuticals Headlines

No Headlines